Pandion Therapeutics, Inc. Common Stock Underwriting AgreementUnderwriting Agreement • July 13th, 2020 • Pandion Therapeutics Holdco LLC • Pharmaceutical preparations • New York
Pandion Therapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as the representatives (the “Representatives”), an aggregate of [•] shares (the “Firm Shares”) and, at the election of the Underwriters, up to [•] additional shares (the “Optional Shares”) of common stock, par value $[•] per share (“Stock”), of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
EMPLOYMENT AGREEMENTEmployment Agreement • July 13th, 2020 • Pandion Therapeutics Holdco LLC • Pharmaceutical preparations • Massachusetts
THIS EMPLOYMENT AGREEMENT (the “Agreement”), is made as of July 10th, 2020 by and between Pandion Therapeutics, Inc. (the “Company”), and Jo Viney (the “Executive”) (together, the “Parties”).
Pandion Therapeutics, Inc. STOCK OPTION AGREEMENTStock Option Agreement • July 13th, 2020 • Pandion Therapeutics Holdco LLC • Pharmaceutical preparations
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
Pandion Therapeutics, Inc. RESTRICTED STOCK UNIT AGREEMENTRestricted Stock Unit Agreement • July 13th, 2020 • Pandion Therapeutics Holdco LLC • Pharmaceutical preparations • Delaware
This grant of RSUs satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
AMENDED AND RESTATED OPERATING AGREEMENT OF PANDION THERAPEUTICS HOLDCO LLC MARCH 23, 2020Operating Agreement • July 13th, 2020 • Pandion Therapeutics Holdco LLC • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED OPERATING AGREEMENT of PANDION THERAPEUTICS HOLDCO LLC, a Delaware limited liability company (the “Company”), dated as of March 20, 2020 (the “Agreement Date”), is by and among the Company and the Members (as defined below).
LICENSE AND COLLABORATION AGREEMENT by and between PANDION THERAPEUTICS, INC. and ASTELLAS PHARMA INC.License and Collaboration Agreement • July 13th, 2020 • Pandion Therapeutics Holdco LLC • Pharmaceutical preparations • New York
This LICENSE AND COLLABORATION AGREEMENT (this “Agreement”) is made as of October 30, 2019 (the “Effective Date”), by and between Pandion Therapeutics, Inc., a corporation organized and existing under the laws of Delaware, having its principal place of business at 610 Main Street, Cambridge, MA 02139, USA (“Pandion”), and Astellas Pharma Inc., a corporation organized and existing under the laws of Japan, having its registered office at 2-5-1, Nihonbashi-Honcho Chuo-ku, Tokyo 103-8411, Japan (“Astellas”). Astellas and Pandion are referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
